Doctor Mate

Minato, Japan Founded: 2017 • Age: 9 yrs
Virtual doctor consultations are facilitated via an online platform.

About Doctor Mate

Doctor Mate is a Healthcare company based in Minato (Japan) founded in 2017. Virtual doctor consultations are facilitated via an online platform. Doctor Mate has raised $7.81 million across 2 funding rounds from investors including Sumitomo Mitsui Banking Corporation, DBJ Capital and The Norinchukin Bank. Its website doctormate.co.jp draws about 89 thousand monthly visits. Its focus areas include HealthTech, Healthcare Booking Platforms, Doctors and Telemedicine. Its competitors include Unlace, UrDoc and Mediction.

Company details

Founded in 2017 and based in Minato City, Japan, Doctor Mate operates in the healthcare sector as an online platform. Virtual consultations are offered to long-term care facilities through chat, voice calls, or video calls. Photos and videos can be shared by patients with doctors during sessions. The domain doctormate.co.jp supports these services for remote medical interactions.

  • Headquarters Minato, Japan
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website doctormate.co.jp
  • Social X Facebook Instagram
Key Metrics

Funding Insights of Doctor Mate

Doctor Mate has successfully raised a total of $7.81M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $7.81M
  • Total Rounds 2
  • First Round $7.81M

    (May 2022)

  • Investors Count 4

All 2 funding rounds of Doctor Mate with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2024Series C–DBJ Capital, Sumitomo Mitsui Banking Corporation
–
May 2022$7.81MSeries B–DBJ Capital, Sumitomo Mitsui Banking Corporation
–
Valuation history

4 investors in total: 4 institutional.

Investors in Doctor Mate

Doctor Mate has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Sumitomo Mitsui Banking Corporation, DBJ Capital and The Norinchukin Bank.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Venture capital investments are provided to innovative startups by DBJ Capital.
dbj-cap.jpJapan
Venture capital firm backed by Aflac Inc
aflacventures.comColumbus, United States
Digital subsidiaries bank offering online banking services
1876smbc.co.jpChiyoda City, Japan
A commercial bank providing a range of financial services to businesses.
1923nochubank.or.jpChiyoda City, Japan
Premium access

Investor details for Doctor Mate

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Doctor Mate

3 dated milestones of Doctor Mate across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded Doctor Mate is founded.
  2. Funding First funding round of $7.8M.
  3. Funding Latest funding round, Series C,.

Competitors of Doctor Mate

Doctor Mate has 3 listed competitors in our database. They include Unlace, UrDoc and Mediction.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
unlace.net2020Shibuya, Japan
Online teleconsultation tool for professionals and patients
ur-doc.com2017Aomori, Japan
Foreign visitors are connected to doctors for language-based teleconsultations.
mediction.co.jp2018Minato, Japan
Medical information is translated in real-time via an AI platform.
Premium access

Detailed competitors of Doctor Mate

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Doctor Mate

The website of Doctor Mate (doctormate.co.jp) receives about 89.4K visits a month and ranks #469,235 among all websites worldwide, #446 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    89.4K

    ▼ 3.6% vs previous month

  • Unique visitors
    52.5K

    per month

  • Global rank
    #469,235

    among all websites

  • Category rank
    #446

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Doctor Mate. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
on-call.jp
100%
5.8K#1,014,650View details
jinentai.com
jinentai.com
90%
#646,361–
maruishi-pharm.co.jp
maruishi-pharm.co.jp
90%
#719,228–
cocoro.clinic
cocoro.clinic
90%
#1,780,829–
mdv.co.jp
90%
36.9K#512,785View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for Doctor Mate

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Doctor Mate

Doctor Mate raises 1 billion yen in Series C
Koureisha-Jutaku β€’ 2 years ago
Premium access

Complete news archive for Doctor Mate

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Doctor Mate

Doctor Mate was founded in 2017 and raised its 1st funding round 5 years after it was founded.

Doctor Mate is headquartered in Minato, Japan. It is registered at Minato, Tokyo, Japan.

Doctor Mate is a funded company, having raised a total of $7.81M across 2 funding rounds to date. The company's 1st funding round was a Series B of $7.81M, raised on May 2022.

Founded in 2017 and based in Minato City, Japan, Doctor Mate operates in the healthcare sector as an online platform. Virtual consultations are offered to long-term care facilities through chat, voice calls, or video calls. Photos and videos can be shared by patients with doctors during sessions. The domain doctormate.co.jp supports these services for remote medical interactions.

Doctor Mate's top competitors include Unlace, UrDoc and Mediction.

Doctor Mate has 4 investors. Key investors include Sumitomo Mitsui Banking Corporation, DBJ Capital, The Norinchukin Bank, and Aflac Ventures.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available